The Journal of International
Advanced Otology
Original Article

Clinical Characteristics and Corticosteroid Responses of Acoustic Neuroma Treated as Idiopathic Sudden Sensorineural Hearing Loss

1.

Department of Otorhinolaryngology, Head and Neck Surgery, Kitasato University, Kanagawa, Japan

2.

Department of Otorhinolaryngology, Head and Neck Surgery, National Defense Medical College, Saitama, Japan

3.

School of Allied Health Sciences, Kitasato University, Kanagawa, Japan

J Int Adv Otol 2023; 19: 5-9
DOI: 10.5152/iao.2023.22720
Read: 366 Downloads: 63 Published: 01 January 2023

BACKGROUND: Few investigations have been conducted on the clinical characteristics of the differential diagnosis of acoustic neuroma with acute sensorineural hearing loss and idiopathic sudden sensorineural hearing loss. The aim of the study was to investigate the clinical characteristics of the differential diagnoses between acoustic neuroma and idiopathic sudden sensorineural hearing loss.

METHODS: The medical records of patients with acute sensorineural hearing loss (142 ears), including acoustic neuroma (19 ears) and idiopathic sudden sensorineural hearing loss (123 ears), who underwent audiometric and hematologic examinations and received systemic corticosteroid treatment, were retrospectively reviewed.

RESULTS: Hematological examination revealed that the erythrocyte sedimentation rate and fibrinogen values were significantly higher in the idiopathic sudden sensorineural hearing loss group compared to the acoustic neuroma group. Although all patients received corticosteroid treatment, hearing thresholds at the initial examination and 3 months after corticosteroid treatment were significantly higher in the idiopathic sudden sensorineural hearing loss group compared to the acoustic neuroma group at all frequencies. However, hearing recovery was worse in the acoustic neuroma group compared to the idiopathic sudden sensorineural hearing loss group. Furthermore, speech discrimination and short increment sensitivity index tests were not significantly different between the acoustic neuroma and idiopathic sudden sensorineural hearing loss groups.

CONCLUSION: This is the first study to reveal that speech discrimination and short increment sensitivity index tests are not useful for the differential diagnoses between acoustic neuroma and idiopathic sudden sensorineural hearing loss, whereas erythrocyte sedimentation rate and fibrinogen, blood biomarkers of inflammation and blood viscosity, would be considered valuable. Furthermore, acoustic neuroma should be considered in cases where acute sensorineural hearing loss did not recover after corticosteroid treatment, although the initial hearing loss was mild.

Cite this article as: Nakamura Y, Kurioka T, Sano H, Furuki S, Yamashita T. Clinical characteristics and corticosteroid responses of acoustic neuroma treated as idiopathic sudden sensorineural hearing loss. J Int Adv Otol. 2023;19(1):5-9.

Files
EISSN 2148-3817